Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Head and Neck" returned 10 results:


Phase I Study of Cabazitaxel- PF Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Principal Investigator(s): Krzysztof J. Misiukiewicz

A Randomized Phase III Clinical Trial Comparing Reduced and Standard Radiation Therapy Doses for Locally Advanced HPV 16 Positive Oropharynx Cancer
Principal Investigator(s): Marshall Posner

A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Principal Investigator(s): Richard Bakst

Window of Opportunity Trial of Neoadjuvant ADXS11-001 Vaccination prior to Robot-Assisted Resection of HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Principal Investigator(s): Andrew Sikora

A Phase 2, Open-label Study of the Safety and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients with Advanced Squamous Cell Carcinoma of Head and Neck, Lung, or Esophagus
Principal Investigator(s): Dr. Jorge Gomez

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal SCCA
Principal Investigator(s): Brett Miles

A phase Ib dose escalation/randomized phase II, multicenter, open-label study of BYL719 in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma
Principal Investigator(s): Krzysztof Misiukiewicz

A Randomised, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer
Principal Investigator(s): William Inabnet

Phase II multicenter randomized, double blind, placebo controlled study assessing the efficacy of buparlisib (BKM120) plus paclitaxel vs. placebo plus paclitaxel in patients with platinum pre-treated recurrent or metastatic head and neck squamous cell carcinoma
Principal Investigator(s): Marshall Posner

A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy plus Cetuximab in Combination with VTX 2337 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Principal Investigator(s): Krzysztof Misiukiewicz